The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
Background. Even though intravenous immunoglobulin (IVIG) is a current treatment for Kawasaki disease (KD), 10-20% of patients require additional therapy. This study seeks to investigate the therapeutic effects of glucocorticoids plus IVIG on KD and to ascertain the subsequent effect on plate...
Saved in:
| Main Authors: | Qiong-Qiong Wang, Li-Yun Zheng, Sheng Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2023-08-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/71 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IVIG Resistance in Kawasaki Disease: Clinical and Laboratory Risk Factors and the Potential Role of Administration Timing
by: Peng Y, et al.
Published: (2025-05-01) -
Role of Pyroptosis in IVIG-Resistant Kawasaki Disease and the Establishment of a New Predictive Model
by: Li S, et al.
Published: (2024-12-01) -
Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01) -
Retrospective Cohort Study of Clinical Profile and IVIg Resistance in Children with Incomplete Kawasaki Disease in a Tertiary Care Center
by: Bhaskar Shenoy, et al.
Published: (2022-08-01) -
EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)